194 related articles for article (PubMed ID: 17390372)
1. PTHrP-induced MCP-1 production by human bone marrow endothelial cells and osteoblasts promotes osteoclast differentiation and prostate cancer cell proliferation and invasion in vitro.
Lu Y; Xiao G; Galson DL; Nishio Y; Mizokami A; Keller ET; Yao Z; Zhang J
Int J Cancer; 2007 Aug; 121(4):724-33. PubMed ID: 17390372
[TBL] [Abstract][Full Text] [Related]
2. Monocyte chemotactic protein-1 mediates prostate cancer-induced bone resorption.
Lu Y; Cai Z; Xiao G; Keller ET; Mizokami A; Yao Z; Roodman GD; Zhang J
Cancer Res; 2007 Apr; 67(8):3646-53. PubMed ID: 17440076
[TBL] [Abstract][Full Text] [Related]
3. Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts.
Fizazi K; Yang J; Peleg S; Sikes CR; Kreimann EL; Daliani D; Olive M; Raymond KA; Janus TJ; Logothetis CJ; Karsenty G; Navone NM
Clin Cancer Res; 2003 Jul; 9(7):2587-97. PubMed ID: 12855635
[TBL] [Abstract][Full Text] [Related]
4. Activation of MCP-1/CCR2 axis promotes prostate cancer growth in bone.
Lu Y; Chen Q; Corey E; Xie W; Fan J; Mizokami A; Zhang J
Clin Exp Metastasis; 2009; 26(2):161-9. PubMed ID: 19002595
[TBL] [Abstract][Full Text] [Related]
5. Prostate cancer cells induce osteoblast differentiation through a Cbfa1-dependent pathway.
Yang J; Fizazi K; Peleg S; Sikes CR; Raymond AK; Jamal N; Hu M; Olive M; Martinez LA; Wood CG; Logothetis CJ; Karsenty G; Navone NM
Cancer Res; 2001 Jul; 61(14):5652-9. PubMed ID: 11454720
[TBL] [Abstract][Full Text] [Related]
6. Parathyroid hormone-related protein induces spontaneous osteoclast formation via a paracrine cascade.
Nakchbandi IA; Weir EE; Insogna KL; Philbrick WM; Broadus AE
Proc Natl Acad Sci U S A; 2000 Jun; 97(13):7296-300. PubMed ID: 10829073
[TBL] [Abstract][Full Text] [Related]
7. Macrophage colony-stimulating factor release and receptor expression in bone cells.
Weir EC; Horowitz MC; Baron R; Centrella M; Kacinski BM; Insogna KL
J Bone Miner Res; 1993 Dec; 8(12):1507-18. PubMed ID: 8304053
[TBL] [Abstract][Full Text] [Related]
8. PTHrP regulates angiogenesis and bone resorption via VEGF expression.
Isowa S; Shimo T; Ibaragi S; Kurio N; Okui T; Matsubara K; Hassan NM; Kishimoto K; Sasaki A
Anticancer Res; 2010 Jul; 30(7):2755-67. PubMed ID: 20683010
[TBL] [Abstract][Full Text] [Related]
9. Importance of membrane- or matrix-associated forms of M-CSF and RANKL/ODF in osteoclastogenesis supported by SaOS-4/3 cells expressing recombinant PTH/PTHrP receptors.
Itoh K; Udagawa N; Matsuzaki K; Takami M; Amano H; Shinki T; Ueno Y; Takahashi N; Suda T
J Bone Miner Res; 2000 Sep; 15(9):1766-75. PubMed ID: 10976996
[TBL] [Abstract][Full Text] [Related]
10. Nuclear localization of type I parathyroid hormone/parathyroid hormone-related protein receptors in deer antler osteoclasts: evidence for parathyroid hormone-related protein and receptor activator of NF-kappaB-dependent effects on osteoclast formation in regenerating mammalian bone.
Faucheux C; Horton MA; Price JS
J Bone Miner Res; 2002 Mar; 17(3):455-64. PubMed ID: 11874237
[TBL] [Abstract][Full Text] [Related]
11. Monocyte Chemoattractant Protein-1 (MCP-1/CCL2) Drives Activation of Bone Remodelling and Skeletal Metastasis.
Mulholland BS; Forwood MR; Morrison NA
Curr Osteoporos Rep; 2019 Dec; 17(6):538-547. PubMed ID: 31713180
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer cells interact with osteoblasts to support osteoclast formation.
Thomas RJ; Guise TA; Yin JJ; Elliott J; Horwood NJ; Martin TJ; Gillespie MT
Endocrinology; 1999 Oct; 140(10):4451-8. PubMed ID: 10499498
[TBL] [Abstract][Full Text] [Related]
13. PTHrP produced by myeloma plasma cells regulates their survival and pro-osteoclast activity for bone disease progression.
Cafforio P; Savonarola A; Stucci S; De Matteo M; Tucci M; Brunetti AE; Vecchio VM; Silvestris F
J Bone Miner Res; 2014 Jan; 29(1):55-66. PubMed ID: 23787729
[TBL] [Abstract][Full Text] [Related]
14. Cyclin D1 as a target for the proliferative effects of PTH and PTHrP in early osteoblastic cells.
Datta NS; Pettway GJ; Chen C; Koh AJ; McCauley LK
J Bone Miner Res; 2007 Jul; 22(7):951-64. PubMed ID: 17501623
[TBL] [Abstract][Full Text] [Related]
15. The chemokine Cxcl1 is a novel target gene of parathyroid hormone (PTH)/PTH-related protein in committed osteoblasts.
Onan D; Allan EH; Quinn JM; Gooi JH; Pompolo S; Sims NA; Gillespie MT; Martin TJ
Endocrinology; 2009 May; 150(5):2244-53. PubMed ID: 19147675
[TBL] [Abstract][Full Text] [Related]
16. RANK ligand is a prerequisite for cancer-associated osteolytic lesions.
Kitazawa S; Kitazawa R
J Pathol; 2002 Oct; 198(2):228-36. PubMed ID: 12237883
[TBL] [Abstract][Full Text] [Related]
17. Osteolytic prostate cancer cells induce the expression of specific cytokines in bone-forming osteoblasts through a Stat3/5-dependent mechanism.
Schulze J; Albers J; Baranowsky A; Keller J; Spiro A; Streichert T; Zustin J; Amling M; Schinke T
Bone; 2010 Feb; 46(2):524-33. PubMed ID: 19796718
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-33, a target of parathyroid hormone and oncostatin m, increases osteoblastic matrix mineral deposition and inhibits osteoclast formation in vitro.
Saleh H; Eeles D; Hodge JM; Nicholson GC; Gu R; Pompolo S; Gillespie MT; Quinn JM
Endocrinology; 2011 May; 152(5):1911-22. PubMed ID: 21363931
[TBL] [Abstract][Full Text] [Related]
19. EphrinB2 regulation by PTH and PTHrP revealed by molecular profiling in differentiating osteoblasts.
Allan EH; Häusler KD; Wei T; Gooi JH; Quinn JM; Crimeen-Irwin B; Pompolo S; Sims NA; Gillespie MT; Onyia JE; Martin TJ
J Bone Miner Res; 2008 Aug; 23(8):1170-81. PubMed ID: 18627264
[TBL] [Abstract][Full Text] [Related]
20. Transient exposure to PTHrP (107-139) exerts anabolic effects through vascular endothelial growth factor receptor 2 in human osteoblastic cells in vitro.
de Gortázar AR; Alonso V; Alvarez-Arroyo MV; Esbrit P
Calcif Tissue Int; 2006 Nov; 79(5):360-9. PubMed ID: 17120184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
